Carisma Therapeutics is a biotechnology company developing cellular immunotherapies. Founded by Michael Klichinsky and Saar Gill in 2016, Carisma Therapeutics is backed by investors that include Agent Capital, IP Group Plc, MRL Ventures Fund, Penn Medicine, and Wellington Partners and is headquartered in Philadelphia.